Centene reports third-quarter adjusted EPS
Valid market news retained in the public archive without immediate LiveCast distribution.
Related stories
PharmaMar net profit falls 43% in first nine months of 2026
PharmaMar reported net profit for the first nine months of 2026, down 43%.
M impact | EARNINGS | Oct 29, 2026, 04:50 PM UTC
PharmaMar Reports First-Nine-Month Net Income Down 43% to €8.7 Million
M impact | EARNINGS | Oct 29, 2026, 04:50 PM UTC
PharmaMar Reports Lower Nine-Month Profit and Higher Revenue
PharmaMar reported a decline in nine-month profit and an increase in revenue.
M impact | EARNINGS | Oct 29, 2026, 04:50 PM UTC
Net Insight Q3 Sales Fall 29% Year Over Year
Net Insight said Q3 2026 sales fell 29% year over year to SEK; the reported figure is incomplete.
M impact | EARNINGS | Oct 29, 2026, 04:49 PM UTC
AXA Sees 2026 Underlying EPS Growth at High End of Target Range
M impact | EARNINGS | Oct 29, 2026, 04:49 PM UTC
AXA targets 2026 underlying EPS growth at top of range
AXA targets underlying earnings-per-share growth at the top of its target range in 2026.
M impact | EARNINGS | Oct 29, 2026, 04:49 PM UTC